We've found
6,666
archived clinical trials in
Hospital
We've found
6,666
archived clinical trials in
Hospital
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Updated: 2/10/2016
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Aerobic Training for Management of Post-Concussion Syndrome in Adolescents
Updated: 2/10/2016
Aerobic Training for Management of Post-Concussion Syndrome in Adolescents
Status: Enrolling
Updated: 2/10/2016
Aerobic Training for Management of Post-Concussion Syndrome in Adolescents
Updated: 2/10/2016
Aerobic Training for Management of Post-Concussion Syndrome in Adolescents
Status: Enrolling
Updated: 2/10/2016
Click here to add this to my saved trials
Genomics and Postoperative Atrial Fibrillation
Updated: 2/11/2016
Genomics and Postoperative Atrial Fibrillation
Status: Enrolling
Updated: 2/11/2016
Genomics and Postoperative Atrial Fibrillation
Updated: 2/11/2016
Genomics and Postoperative Atrial Fibrillation
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Biomechanical Validation of the Transfer Assessment Instrument (TAI)
Updated: 2/11/2016
Biomechanical Validation of the Transfer Assessment Instrument (TAI)
Status: Enrolling
Updated: 2/11/2016
Biomechanical Validation of the Transfer Assessment Instrument (TAI)
Updated: 2/11/2016
Biomechanical Validation of the Transfer Assessment Instrument (TAI)
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Evaluation of Efficacy and Accuracy of a Cordless Ultrasonic Dissection System
Updated: 2/11/2016
Sonicision Cordless Ultrasonic Dissection System in General Surgery: A Prospective Post-market Observational Study to Evaluate the Efficacy and Accuracy of a Cordless Ultrasonic Dissection System
Status: Enrolling
Updated: 2/11/2016
Evaluation of Efficacy and Accuracy of a Cordless Ultrasonic Dissection System
Updated: 2/11/2016
Sonicision Cordless Ultrasonic Dissection System in General Surgery: A Prospective Post-market Observational Study to Evaluate the Efficacy and Accuracy of a Cordless Ultrasonic Dissection System
Status: Enrolling
Updated: 2/11/2016
Click here to add this to my saved trials
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
Updated: 2/12/2016
A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Craniotomy
Status: Enrolling
Updated: 2/12/2016
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
Updated: 2/12/2016
A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Craniotomy
Status: Enrolling
Updated: 2/12/2016
Click here to add this to my saved trials
Cell Therapy for Craniofacial Bone Defects
Updated: 2/15/2016
Cell Therapy for Craniofacial Bone Defects
Status: Enrolling
Updated: 2/15/2016
Cell Therapy for Craniofacial Bone Defects
Updated: 2/15/2016
Cell Therapy for Craniofacial Bone Defects
Status: Enrolling
Updated: 2/15/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Updated: 2/16/2016
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
REperfusion With Cooling in CerebraL Acute IscheMia II
Updated: 2/16/2016
REperfusion With Cooling in CerebraL Acute IscheMia II
Status: Enrolling
Updated: 2/16/2016
REperfusion With Cooling in CerebraL Acute IscheMia II
Updated: 2/16/2016
REperfusion With Cooling in CerebraL Acute IscheMia II
Status: Enrolling
Updated: 2/16/2016
Click here to add this to my saved trials
Cardiometabolic Risk, Obesity and Cardiovascular Disease in People With Spinal Cord Injury
Updated: 2/17/2016
Cardiometabolic Risk, Obesity and Cardiovascular Disease in People With Spinal Cord Injury
Status: Enrolling
Updated: 2/17/2016
Cardiometabolic Risk, Obesity and Cardiovascular Disease in People With Spinal Cord Injury
Updated: 2/17/2016
Cardiometabolic Risk, Obesity and Cardiovascular Disease in People With Spinal Cord Injury
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Primary-care-provider Identification And Notification
Updated: 2/17/2016
Identifying Primary Care Providers and Notifying Them Upon Admission of Their Patients to New York-Presbyterian Hospital
Status: Enrolling
Updated: 2/17/2016
Primary-care-provider Identification And Notification
Updated: 2/17/2016
Identifying Primary Care Providers and Notifying Them Upon Admission of Their Patients to New York-Presbyterian Hospital
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Updated: 2/18/2016
Randomized, Double-Blind Trial of Clindamycin, Trimethoprim-Sulfamethoxazole, or Placebo for Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Propofol Versus Sevoflurane Recovery After Gynecological Surgery
Updated: 2/18/2016
The Effects of Propofol vs. Sevoflurane Administered During Anesthesia Maintenance on Early and Late Recovery After Gynecological Surgery
Status: Enrolling
Updated: 2/18/2016
Propofol Versus Sevoflurane Recovery After Gynecological Surgery
Updated: 2/18/2016
The Effects of Propofol vs. Sevoflurane Administered During Anesthesia Maintenance on Early and Late Recovery After Gynecological Surgery
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
Updated: 2/18/2016
A Prospective Trial of the Copper T380 IUD or Oral Levonorgestrel and the Levonorgestrel IUD Initiated With Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
Updated: 2/18/2016
A Prospective Trial of the Copper T380 IUD or Oral Levonorgestrel and the Levonorgestrel IUD Initiated With Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
Updated: 2/18/2016
Preventing Future Pregnancy After Choosing the Copper IUD vs. Oral Levonorgestrel for Emergency Contraception
Status: Enrolling
Updated: 2/18/2016
Click here to add this to my saved trials
Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Updated: 2/19/2016
Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Status: Enrolling
Updated: 2/19/2016
Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Updated: 2/19/2016
Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Deep Brain Stimulation for Traumatic Brain Injury
Updated: 2/19/2016
Deep Brain Stimulation for Treatment of Severe Disability From Traumatic Brain Injury
Status: Enrolling
Updated: 2/19/2016
Deep Brain Stimulation for Traumatic Brain Injury
Updated: 2/19/2016
Deep Brain Stimulation for Treatment of Severe Disability From Traumatic Brain Injury
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery
Updated: 2/19/2016
Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting (PONV) in Bariatric Surgery
Status: Enrolling
Updated: 2/19/2016
Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery
Updated: 2/19/2016
Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting (PONV) in Bariatric Surgery
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Post-traumatic Arthritis Associated With Joint Injury
Updated: 2/19/2016
Assessment of Biomarkers Associated With Joint Injury and Subsequent Post-Traumatic Arthritis
Status: Enrolling
Updated: 2/19/2016
Post-traumatic Arthritis Associated With Joint Injury
Updated: 2/19/2016
Assessment of Biomarkers Associated With Joint Injury and Subsequent Post-Traumatic Arthritis
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Updated: 2/19/2016
Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Status: Enrolling
Updated: 2/19/2016
Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus
Updated: 2/19/2016
Phase I Evaluation of a CMV-MVA Triplex Vaccine: Safety and Biologically Effective Dose in Healthy Volunteers With or Without Prior Immunity to CMV and Vaccinia
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Updated: 2/19/2016
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Status: Enrolling
Updated: 2/19/2016
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Updated: 2/19/2016
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Status: Enrolling
Updated: 2/19/2016
Click here to add this to my saved trials
ECG Leadwires: Disposable Versus Cleaned, Reusable
Updated: 2/21/2016
ECG Leadwires: Do Disposable Leadwires Reduce the Incidence of Bacterial Infections in ICU Patients and Provide Adequate Signaling in Stepdown/Telemetry Environment Compared to Cleaned Reusable ECG Leadwires?
Status: Enrolling
Updated: 2/21/2016
ECG Leadwires: Disposable Versus Cleaned, Reusable
Updated: 2/21/2016
ECG Leadwires: Do Disposable Leadwires Reduce the Incidence of Bacterial Infections in ICU Patients and Provide Adequate Signaling in Stepdown/Telemetry Environment Compared to Cleaned Reusable ECG Leadwires?
Status: Enrolling
Updated: 2/21/2016
Click here to add this to my saved trials
Intermountain Risk Score and Trauma
Updated: 2/22/2016
The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients
Status: Enrolling
Updated: 2/22/2016
Intermountain Risk Score and Trauma
Updated: 2/22/2016
The Intermountain Risk Score's Association With Mortality Prediction in Trauma Patients
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Hemodialysis Vascular Access Imaging Study
Updated: 2/22/2016
Contact-Free Video Imaging of Arteriovenous Fistulas In Chronic Hemodialysis Patients
Status: Enrolling
Updated: 2/22/2016
Hemodialysis Vascular Access Imaging Study
Updated: 2/22/2016
Contact-Free Video Imaging of Arteriovenous Fistulas In Chronic Hemodialysis Patients
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Updated: 2/25/2016
A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/25/2016
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Updated: 2/25/2016
A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Updated: 2/25/2016
A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/25/2016
Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
Updated: 2/25/2016
A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus Aureus
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials